REG - Smithson Inv.Trust - Update on CBI Approval re Smithson Equity Fund

Smithson Investment TrustAnnouncement

05/02/2026 14:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260205:nRSE9330Ra&default-theme=true

RNS Number : 9330R  Smithson Investment Trust PLC  05 February 2026

For immediate release.

5 February 2026

 

Smithson Investment Trust plc

 

Legal Entity Identifier: 52990070BDK2OKX5TH79

 

Update on Central Bank of Ireland Approval relating to Smithson Equity Fund

 

On 12 November 2025, the Board of Smithson Investment Trust plc (the
"Company") announced that it would put forward proposals for the scheme of
reconstruction and members' voluntary winding-up of the Company under section
110 of the Insolvency Act 1986 (the "Scheme") pursuant to which Shareholders
would have the option to roll over their investment in the Company (in whole
or in part) into Smithson Equity Fund (the "Fund"), a UK OEIC established in
conjunction with the Scheme. A circular in relation to the Scheme was
published and posted to Shareholders and CSN Participants on 22 January 2026
(the "Circular").

The Company is pleased to announce that the requisite regulatory approvals in
connection with the marketing of the Fund to investors in the Republic of
Ireland have been obtained from the Central Bank of Ireland. Therefore,
Shareholders and CSN Participants who have a registered address or are
resident in, or are citizens or nationals of, the Republic of Ireland (other
than US Persons and Sanctions Restricted Persons) ("ROI Investors") are
eligible to receive Fund Shares and to participate in the Rollover Option.
Accordingly, ROI Investors who, prior to the Elections Deadline, have not
validly elected, or validly instructed an Election, for the Cash Option will
be deemed to have elected, or instructed an Election, for the Rollover Option
(i.e. receive Fund Shares) in respect of their entire holding.

ROI Investors, and other Shareholders and CSN Participants, are encouraged to
take action in respect of the Proposals by:

·      voting, or instructing their votes, on the Resolutions required
to approve the Scheme and related matters at the General Meetings; and

·      making, or instructing the making of, Elections under the Scheme
for (i) the Cash Option; (ii) the Rollover Option; or (iii) a combination of
both.

The attention of ROI Investors and other Shareholders and CSN Participants is
drawn to the section titled "Action to be taken" on pages 5 to 11 of the
Circular. Full details of the action to be taken by Shareholders and CSN
Participants are set out in paragraph 14 of Part 1 of the Circular and in the
instructions contained in the Forms of Proxy, Forms of Instruction, Form of
Election and CSN Form of Election (as applicable).

Before taking any action in connection with the Proposals, Shareholders and
CSN Participants are recommended to read the whole of the Circular and the
Fund Documents which are available at www.smithson.co.uk/restructure-proposal.
In addition, ROI Investors should read the Fund Prospectus Irish Supplement,
which is also available at www.smithson.co.uk/restructure-proposal. Please
note that the Company and its Board take no responsibility for the contents of
the Fund Documents. Shareholders and CSN Participants who are in any doubt as
to the contents of this announcement, the Circular or the Fund Documents or as
to the action to be taken should consult their stockbroker, bank manager,
solicitor, accountant or other financial adviser authorised under FSMA,
without delay.

Defined terms used in this announcement have the meanings given in the
Circular unless the context otherwise requires.

The person responsible for arranging for the release of this announcement on
behalf of the Company is Apex Listed Companies Services (UK) Limited, the
Company Secretary.

 

Expected Timetable

 

 Latest time and date for receipt of online voting instructions and GREEN Forms   11.00 a.m. on 5 February
 of Instruction from CSN Participants in respect of the First General Meeting
 Latest time and date for receipt of electronic proxy appointments, CREST         11.00 a.m. on 6 February
 voting instructions and PINK Forms of Proxy from  Shareholders in respect of
 the First General Meeting
 Latest time and date for receipt of YELLOW CSN Forms of Election                 1.00 p.m. on 9 February
 First General Meeting                                                            11.00 a.m. on 10 February
 Latest time and date for receipt of WHITE Forms of Election and TTE              1.00 p.m. on 10 February
 Instructions
 Calculation Date for the Scheme                                                  6.00 p.m. on 10 February
 Record Date for entitlements under the Scheme                                    6.00 p.m. on 10 February
 Shares disabled in CREST                                                         6.00 p.m. on 10 February
 Suspension of trading in Shares                                                  7.30 a.m. on 11 February
 Payment date for the SSON Interim Dividend                                       20 February
 Latest time and date for receipt of online voting instructions and PURPLE        9.30 a.m. on 24 February
 Forms of Instruction from CSN Participants in respect of the Second General
 Meeting
 Reclassification of the Shares and commencement of trading in Reclassified       8.00 a.m. on 25 February
 Shares
 Latest time and date for receipt of electronic proxy appointments, CREST         9.30 a.m. on 25 February
 voting instructions and BLUE Forms of Proxy in respect of the Second General
 Meeting
 Suspension of trading in Reclassified Shares and the Register closes             7.30 a.m. on 27 February
 Second General Meeting                                                           9.30 a.m. on 27 February
 Appointment of the Liquidators                                                   27 February
 Effective Date and Transfer Agreement executed and implemented                   27 February
 Announcement of Elections under the Scheme, the Cash FAV per Share, the Final    27 February
 Rollover FAV and the number of Fund Shares to be issued pursuant to the Scheme
 Fund Shares issued pursuant to the Scheme                                        27 February
 First day of dealing in Fund Shares                                              2 March
 Contract notes expected to be despatched in respect of Fund Shares issued        as soon as practicable after the Effective Date
 pursuant to the Scheme
 Electronic payments or cheques expected to be despatched and CREST payments      not later than 10 Business Days after the Effective Date
 made to Shareholders and CSN Participants in respect of the Cash Option
 Cancellation of listing of Reclassified Shares                                   as soon as practicable after the Effective Date
 Note: All references to time in this announcement are to UK time. Each of the
 times and dates in the above expected transaction timetable may be extended or
 brought forward. If any of the above times and/or dates change, the revised
 time(s) and/or date(s) will be notified to Shareholders and CSN Participants
 by an announcement through a Regulatory Information Service.

 

 

Enquiries:

 

 Smithson Investment Trust plc                                              c/o Burson Buchanan

 Mike Balfour, Chairman
 J.P. Morgan Cazenove (Sole Financial Adviser)                              +44 (0) 203 493 8000

 William Simmonds

 Rupert Budge
 Burson Buchanan (Financial PR)                                             smithson@buchanancomms.co.uk (mailto:Smithson@buchanancomms.co.uk)

 Henry Wilson                                                               +44 (0) 7788 528143

 Helen Tarbet                                                               +44 (0) 7872 604453

 Nick Croysdill                                                             +44 (0) 7815 823412
 Apex Listed Companies Services (UK) Limited (Corporate Company Secretary)  +44 (0) 203 327 9720

 

 

This announcement is not for publication or distribution in or into the United
States of America.  This announcement is not an offer of securities for sale
into the United States.  The securities referred to herein have not been and
will not be registered under the U.S. Securities Act of 1933, as amended, and
may not be offered or sold in the United States, except pursuant to an
applicable exemption from registration.  No public offering of securities is
being made in the United States.

 

LEI: 52990070BDK2OKX5TH79

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFLFSVFSIEIIR



            Copyright 2019 Regulatory News Service, all rights reserved